How is Alexander disease diagnosed?

Diagnosis of Alexander Disease

Alexander disease is diagnosed through a combination of characteristic MRI findings and confirmatory genetic testing for GFAP gene mutations, with brain biopsy now rarely necessary except in atypical cases. 1, 2

Diagnostic Algorithm

Step 1: Clinical Suspicion

Suspect Alexander disease based on age-specific presentations:

Infantile-onset (most common):

• Seizures and megalencephaly
• Developmental delays
• Progressive neurological deterioration 2

Juvenile/Adult-onset:

• Bulbar signs (dysarthria, dysphagia)
• Ataxia
• Autonomic dysfunction
• Spastic paraparesis 3, 4
• May present with psychiatric symptoms (depression, cognitive decline) 5

Step 2: MRI Brain (Primary Diagnostic Tool)

MRI is highly sensitive and can establish diagnosis without biopsy. 1 Five key MRI criteria have been defined:

1. Extensive cerebral white matter changes with frontal predominance
2. Periventricular rim: High signal on T1-weighted images, low signal on T2-weighted images
3. Abnormalities of basal ganglia and thalami
4. Brain stem abnormalities
5. Contrast enhancement of particular gray and white matter structures

Diagnosis requires 4 of 5 criteria to be met. 1

Step 3: Confirmatory Genetic Testing

GFAP gene sequencing is the confirmatory assay and should be included in the initial diagnostic evaluation. 2

• Screen the entire coding region including exon-intron boundaries
• Approximately 90% of patients with characteristic MRI findings will have GFAP mutations 2
• Mutations are typically heterozygous, single amino acid changes that alter protein charge
• Whole exome sequencing may be necessary for atypical presentations or when standard sequencing is negative 4

Step 4: Exclusionary Testing

Before proceeding to GFAP testing, ensure:

• Normal karyotype
• Normal metabolic screening
• Unremarkable family history (most cases are sporadic) 2

Important Clinical Pearls

Brain biopsy is no longer required for diagnosis in patients meeting MRI criteria with confirmed GFAP mutations. Biopsy showing Rosenthal fibers is only necessary in atypical cases where MRI and genetic testing are inconclusive. 1

Asymptomatic or minimally symptomatic patients can be diagnosed if they have characteristic MRI findings and GFAP mutations, allowing for earlier monitoring and potential future interventions. 2

Late-onset presentations are diagnostically challenging because symptoms are non-specific and may mimic other conditions. Maintain high suspicion in adults with unexplained progressive neurological symptoms, particularly with bulbar involvement or spastic paraparesis combined with white matter changes on MRI. 3, 4

Psychiatric symptoms may be the initial presentation in adult-onset disease, appearing years before neurological signs become apparent. Consider Alexander disease in treatment-resistant psychiatric cases with soft neurological signs or cognitive decline. 5

Diagnostic Pitfalls to Avoid

• Do not wait for classic infantile presentation; late-onset forms have variable, milder symptoms
• Do not rely solely on genetic testing without MRI correlation, as some variants may be of uncertain significance
• Do not dismiss the diagnosis in adults presenting with isolated psychiatric symptoms
• Do not perform brain biopsy as first-line diagnostic test when non-invasive methods are available